JPMORGAN CHASE & CO

Holdings History for 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT)

Symbol: FDMT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$2,096,289	279,505	-234,010	-46%	$7.50	Q4 2025
30 Sep 2025	0%	-0%	$4,462,445	513,515	-374,501	-42%	$8.69	Q3 2025
30 Jun 2025	0%	0%	$3,294,539	888,016	+1,311	+0.15%	$3.71	Q2 2025
31 Mar 2025	0%	+0%	$2,864,059	886,705	+66,636		$3.23	Q1 2025
31 Dec 2024	0%	+0%	$4,567,785	820,069	+504,086	+160%	$5.57	Q4 2024
30 Sep 2024	0%	-0%	$3,415,776	315,983	-29,790	-8.6%	$10.81	Q3 2024
30 Jun 2024	0%	-0%	$7,257,775	345,773	-56,768	-14%	$20.99	Q2 2024
31 Mar 2024	0%	-0%	$12,824,957	402,541	-25,849	-6%	$31.86	Q1 2024
31 Dec 2023	0%	-0%	$8,679,181	428,390	-157,061	-27%	$20.26	Q4 2023
30 Sep 2023	0%	+0%	$7,452,792	585,451	+128,237	+28%	$12.73	Q3 2023
30 Jun 2023	0%	+0%	$8,261,857	457,214	+16,901	+3.8%	$18.07	Q2 2023
31 Mar 2023	0%	+0%	$7,569,000	440,313	+339	+0.08%	$17.19	Q1 2023
31 Dec 2022	0%	-0%	$9,772,000	439,974	-13,134	-2.9%	$22.21	Q4 2022
30 Sep 2022	0%	-0%	$3,643,000	453,108	-25,649	-5.4%	$8.04	Q3 2022
30 Jun 2022	0%	+0%	$3,343,000	478,757	+111,317	+30%	$6.98	Q2 2022
31 Mar 2022		0%	$2,000	105	0		$19.05 ^*	Q1 2022
31 Mar 2022	0%	+0%	$5,555,000	367,440	+84,053	+30%	$15.12	Q1 2022
31 Dec 2021	0%	+0%	$6,218,000	283,387	+53,451	+23%	$21.94	Q4 2021
30 Sep 2021	0%	+0%	$6,201,000	229,936	+216,850	+1657%	$26.97	Q3 2021
30 Jun 2021	0%	-0%	$316,000	13,086	-7,785	-37%	$24.15	Q2 2021
31 Mar 2021	0%	+0%	$905,000	20,871	+20,871	NEW	$43.36	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.